Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

November-December 2025 (Vol. 22 Issue 6) Table of Contents
Cancer Genomics - Proteomics: 22 (6)

Issue highlights

  • C1orf50 Accelerates Epithelial-Mesenchymal Transition and the Cell Cycle of Hepatocellular Carcinoma
  • Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators
  • Lower SYNJ2BP Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis
  • Immunoliposome for Ewing Sarcoma
  • Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma

 


 

⚠️ Important Notice: Fraudulent Emails

We have been informed of fraudulent emails impersonating IIAR editors and requesting financial assistance or bank transfers. These messages do NOT come from us.

Please note that the ONLY official IIAR email domains are:

  • @iiar-anticancer.org
  • @iiar-submissions.com

If you receive any suspicious message from another address—especially requests involving money—do not respond. Report the message as spam/phishing and contact us directly through our official email addresses.

Thank you for your vigilance.

Featured Articles

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human...
    September 04, 2017
  • The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan
    April 25, 2018
  • Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor...
    October 28, 2019
  • WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    December 26, 2015
  • Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical...
    December 26, 2015
  • ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and...
    March 01, 2018

Latest Articles

  • Open Access
    Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma
    MAREK KASIK, ROBERT ILIEV, PETRA VYCHYTILOVA, SILVIA RYBECKA, LENKA RADOVA, MICHAL STANIK, MICHAL FEDORKO, JAN DOLEZEL, ONDREJ SLABY and JULIA BOHOSOVA
    Cancer Genomics & Proteomics November 2025, 22 (6) 888-899; DOI: https://doi.org/10.21873/cgp.20545
  • Open Access
    Immunoliposome for Ewing Sarcoma
    DANIEL E. PANOSYAN, WILLIAM S. PANOSYAN, DARON S. YACOUBIAN and JOSEPH L. LASKY
    Cancer Genomics & Proteomics November 2025, 22 (6) 882-887; DOI: https://doi.org/10.21873/cgp.20544
  • Open Access
    BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells
    KATHARINA WERT, JOHANNA JENTSCH, JULIA GALLWAS and CARSTEN GRÜNDKER
    Cancer Genomics & Proteomics November 2025, 22 (6) 900-911; DOI: https://doi.org/10.21873/cgp.20546
  • Open Access
    SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer
    WEI-LUN HUANG, PEI-FANG HSIEH, SIH-HAN CHEN, RICHARD CHEN-YU WU, HSING-CHA MAI, CHUN-HSIEN WU, SEE-TONG PANG, YU-LIN YANG and VICTOR CHIA-HSIANG LIN
    Cancer Genomics & Proteomics November 2025, 22 (6) 953-970; DOI: https://doi.org/10.21873/cgp.20549
  • Open Access
    Lipid Metabolic Reprogramming During Progression to Castration-resistant Prostate Cancer Identified by Quantitative Proteomics
    HYUNCHAE SIM, SUBIN BAE, CHAI WON PARK, SO YOUNG CHOI, KWANG-HYEON LIU, EUN HYE LEE, BUM SOO KIM, JAE-WOOK CHUNG, YUN-SOK HA, JUN NYUNG LEE, WONHWA LEE, TAE GYUN KWON and SANGKYU LEE
    Cancer Genomics & Proteomics November 2025, 22 (6) 940-952; DOI: https://doi.org/10.21873/cgp.20548
  • Open Access
    Differential Proteomic Analysis of DEN-induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Sex-Specific Markers
    SALMMA SALAMAH SALIHAH, MUHAMMAD TAHIR, BAREERA BIBI, RABIA SULTAN, MARTIN R. LARSEN, MUNAZZA RAZA MIRZA, SANA MAHMOOD, MUHAMMAD RIZWAN ALAM, JAMILA IQBAL, WILLIAM C. CHO and ASMA GUL
    Cancer Genomics & Proteomics November 2025, 22 (6) 912-928; DOI: https://doi.org/10.21873/cgp.20540
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Access CGP at your Mobile Device

Now you can access the entire contents of Cancer Genomics & Proteomics at your Android or iOS device with our newly designed mobile app, freely available through Google Play and App Store.

Visit the official website of Cancer Genomics & Proteomics.
Back to top
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire